raised concerns about the drug's pricing, saying, "We're spending $1,600 a month on this drug, there's a bill right now before congress that will make it available to everybody who is overweight, which is 74 percent of the American population." He continued: "That alone will cost $3 trillion a year
Sakellaris, G., et al
Novel and emerging diabetes mellitus drug therapies for the type 2 diabetes patient
This exceptionally high enzyme stability of the bicyclic and tricyclic GLP-1 analogs would be of interest in achieving a long-acting in vivo activity and molecular imaging of pancreatic -cells via the GLP-1 receptor (vide infra)
Boisvert, C., Pare, C., Veyrat-Durebex, C., Robert, A., Dubuisson, S., Morel, G
Over-relying on whitening foods can create unrealistic expectations